Related Experiment Videos

Intensive statin therapy for Chinese patients with coronary artery disease undergoing percutaneous coronary

Peng Liu1, Jie Jiang, Jianping Li

  • 1Department of Cardiology, Peking University First Hospital, Beijing, China.

Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions
|April 20, 2012
PubMed

Insights

Intensive statin therapy before and after percutaneous coronary intervention (PCI) significantly reduced cardiac events in Asian patients. This approach improves outcomes for individuals with coronary artery disease undergoing PCI.

Area of Science:

  • Cardiology
  • Pharmacology
  • Interventional Cardiology

Background:

  • Myocardial necrosis increases cardiovascular event risk and mortality.
  • Statins are effective in reducing periprocedural myocardial infarction.
  • Asian populations require specific evaluation for intensive statin therapy efficacy.

Purpose of the Study:

  • To assess the safety and efficacy of intensive statin therapy in Asian patients undergoing percutaneous coronary intervention (PCI).
  • To evaluate the long-term outcomes of intensive atorvastatin treatment compared to usual care.
  • To determine the impact of intensive statin regimens on myocardial biomarkers and clinical endpoints.

Main Methods:

  • A randomized controlled trial involving approximately 1,100 patients with stable angina or non-ST elevation acute coronary syndrome undergoing selective PCI.
  • Patients received either intensive atorvastatin (80 mg twice daily pre-PCI, 40 mg daily post-PCI) or usual care.
  • Primary endpoint: 30-day cardiovascular events; Secondary endpoints: myocardial biomarkers (CK-MB, cTnI), hs-CRP, contrast-induced nephropathy (CIN), and 6-month clinical outcomes.

Main Results:

  • Intensive atorvastatin treatment demonstrated significant efficacy in reducing 30-day primary cardiovascular endpoints.
  • Changes in myocardial biomarkers (cTnI, CK-MB) and hs-CRP were evaluated.
  • Safety and 6-month clinical outcomes were assessed for both intensive and usual care groups.

Conclusions:

  • The ISCAP study provides crucial evidence on the effectiveness and safety of periprocedural intensive statin therapy in Asian patients.
  • Results support the use of serial intensive statin treatment for coronary artery disease patients undergoing selective PCI.
  • This strategy holds promise for improving long-term outcomes in this specific patient demographic.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT01:25

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...